Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Neuromodulation on Pain Biomarkers and Functional Outcome in Patients With Fibromyalgia Syndrome

NCT06539793 is registered in ClinicalTrials.gov with Ahmed Alshimy as lead sponsor.

NCT NCT06539793
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06539793 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Neuromodulation on Pain Biomarkers and Functional Outcome in Patients With Fibromyalgia Syndrome
Lead sponsor
Ahmed Alshimy
Phase
Not applicable
Overall status
Recruiting
Start date
September 1, 2024
Completion date
July 3, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia syndrome